EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Klinische Studie (Phase III)Open Access · CC BY-NC-ND 4.0

Intensified pegylated-asparaginase in consolidation therapy improved outcome of allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia

Junjie Chen, Jia Li, Zhixiang Wang, Zicong Huang, Jieping Lin, Jiawang Ou, Xiuli Xu, Bingqing Tang, Chenhao Ding, Zihong Cai, Ren Lin, Xuan Li und 2 weitere

Annals of Hematology · 2025

DOI: 10.1007/s00277-025-06576-8 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Annals of Hematology, 2025. Verfasst von Junjie Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Nanfang Hospital, Southern Medical University, Rd 1838 Guangzhou Avenue, Guangzhou, 510515, China. Hauptthemen laut MEDLINE: Asparaginase, Consolidation Chemotherapy, Hematopoietic Stem Cell Transplantation, Polyethylene Glycols. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Science and Technology Planning Project of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Research on the optimal consolidation therapy for adult T-cell acute lymphoblastic leukemia (T-ALL) remains limited, and how to integrate pediatric-inspired chemotherapy with allogeneic hematopoietic stem cell transplantation (SCT) is less addressed. Based on retrospective analysis indicating that 4 doses of pegylated-asparaginase (PEG-Asp) prior to SCT were optimal for survival, we designed a PEG-Asp-intensified pediatric-inspired regimen, PDT-ALL-2016, for adult T-ALL (NCT03564704). In this protocol, SCT administered following 4 or 5 doses of PEG-Asp. The impact of PEG-Asp on transplantation outcomes was evaluated in two cohorts: the prospective PDT-ALL-2016 cohort (2016.1-2021.12, N = 63) and the retrospective adult regimen cohort (2008.1-2015.12, N = 61). With intensified PEG-Asp consolidation, the prospective cohort exhibited superior survival compared to the retrospective cohort. Furthermore, within the prospective cohort, patients who received non-truncated PEG-Asp demonstrated better survival than those who received a truncated dose. Then, the entire cohort was stratified into high-dose (4-5 doses, N = 45), medium-dose (2-3 doses; N = 33) and low-dose (0-1 doses; N = 46) groups, based on the number of PEG-Asp doses administrated pre-SCT. The high-dose group showed superior survival compared to the other two groups in both the entire cohort and in subgroup analysis. Our findings indicate that high-dose PEG-Asp is associated with improved outcome in adult T-ALL undergoing SCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsparaginaseConsolidation ChemotherapyHematopoietic Stem Cell TransplantationPolyethylene GlycolsPrecursor T-Cell Lymphoblastic Leukemia-LymphomaAdolescentAdultFemaleHumansMaleMiddle AgedYoung AdultProspective StudiesRetrospective StudiesSurvival RateTransplantation, HomologousTreatment Outcome

Stichwörter der Autor:innen

Allogeneic hematopoietic stem cell transplantationAsparaginaseMinimal residual diseaseT-cell acute lymphoblastic leukemia

Substanzen

AsparaginasepegaspargasePolyethylene Glycols

Autor:innen und Institutionen

  • Department of Hematology, Nanfang Hospital, Southern Medical University, Rd 1838 Guangzhou Avenue, Guangzhou, 510515, China.
  • Guangdong Provincial Clinical Research Center for Hematologic Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Hematology, Ganzhou People's Hospital (Nanfang Hospital Ganzhou Hospital), Ganzhou, China.
  • Department of Hematology, Nanfang Hospital, Southern Medical University, Rd 1838 Guangzhou Avenue, Guangzhou, 510515, China. hanson_tcm@126.com.
  • Guangdong Provincial Clinical Research Center for Hematologic Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China. hanson_tcm@126.com.
  • Department of Hematology, Ganzhou People's Hospital (Nanfang Hospital Ganzhou Hospital), Ganzhou, China. hanson_tcm@126.com.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Science and Technology Planning Project of Guangdong Province

Zitieren

APA

Chen, J., Li, J., Wang, Z., Huang, Z., Lin, J., Ou, J., Xu, X., Tang, B., Ding, C., Cai, Z., Lin, R., Li, X., Liu, Q., & Zhou, H. (2025). Intensified pegylated-asparaginase in consolidation therapy improved outcome of allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia. Annals of Hematology. https://doi.org/10.1007/s00277-025-06576-8

Vancouver

Chen J, Li J, Wang Z, Huang Z, Lin J, Ou J, et al. Intensified pegylated-asparaginase in consolidation therapy improved outcome of allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia. Annals of Hematology. 2025. doi:10.1007/s00277-025-06576-8

BibTeX
@article{Chen2025,
  author = {Chen, Junjie and Li, Jia and Wang, Zhixiang and Huang, Zicong and Lin, Jieping and Ou, Jiawang and Xu, Xiuli and Tang, Bingqing and Ding, Chenhao and Cai, Zihong and Lin, Ren and Li, Xuan and Liu, Qifa and Zhou, Hongsheng},
  title = {Intensified pegylated-asparaginase in consolidation therapy improved outcome of allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia},
  journal = {Annals of Hematology},
  year = {2025},
  doi = {10.1007/s00277-025-06576-8}
}
Kostenlos starten →